ADIAL PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Adial Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • Adial Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.21M, a 62.9% decline year-over-year.
  • Adial Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$6.89M, a 36.6% increase from 2022.
  • Adial Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$10.9M, a 43.7% increase from 2021.
  • Adial Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$19.3M, a 76.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$6.89M +$3.97M +36.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$10.9M +$8.43M +43.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$19.3M -$8.36M -76.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$10.9M -$2.68M -32.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 -$8.24M -$1.26M -18% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
2018 -$6.99M -$5.99M -602% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 -$995K Jan 1, 2017 Dec 31, 2017 10-K 2019-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.